In May 2019, TCRCure opened a new research and manufacturing site in the Los Angeles bioscience corridor. The 5000 square foot facility includes 1400 s.f. of GMP-compliant manufacturing space and 1000 s.f. of R&D space, plus additional flex space. Patient cell therapy products will be produced in a 600 square foot ISO 7 cleanroom according to cGMPs for cell-therapy manufacturing. It will be TCRCure’s major site for clinical-grade therapeutic production in the US.
GMP certified Guangdong manufacturing site construction launched
TCRCure’s Guangdong manufacturing site, which includes GMP certified cell production facilities, office space, and labs for quality assurance, research and development, launched construction in Guangdong Medical Valley.
In May 2019, TCRCure opened a new research and manufacturing site in the Los Angeles bioscience corridor. The 5000 square foot facility includes 1400 s.f. of GMP-compliant manufacturing space and 1000 s.f. of R&D space, plus additional flex space. Patient cell therapy products will be produced in a 600 square foot ISO 7 cleanroom according to cGMPs for cell-therapy manufacturing. It will be TCRCure’s major site for clinical-grade therapeutic production in the US.
TCRCure Chongqing Research Institute awarded Chongqing postdoctoral program
TCRCure Chongqing Research Institute was officially awarded the Chongqing Postdoctoral Program by the Chongqing Municipal Human Resources and Social Security Bureau on May 18, 2019.
EN
EN
